AI in Drug DiscoveryBiochemistry / BiophysicsBiologicsCellular and Molecular BiologyEnzymology/Protein Engineering/FermentationIn vitro Testing, TrialsMolecular designNew ModalitiesProtein EngineeringSynthetic BiologyTherapeutic DevelopmentToxicologySmall Molecules
THERAPEUTIC AREA
Cardiology/Vascular DiseasesGenetic DiseaseInfections and Infectious DiseasesOncologyOphthalmologyPharmacology/ToxicologyPulmonary/Respiratory DiseasesRare DiseaseVaccines
We deliver CMC development for small molecules within 7-8 months (DS/DP) and for PROTACs and molecular glues (and TIDES) within ~10 months. Integrated DMPK, toxicology, and bioanalytical services are available within the same timeline.
Author
Business Development Director, Europe at WuXi AppTec